HCG Cancer Hospital in Bangalore is the flagship of HealthCare Global, the largest dedicated cancer network in India. Unlike a general hospital with an oncology department, everything here is built for cancer: radiation therapy, medical oncology, surgical oncology, haematology, nuclear medicine, pathology and palliative care, organised around tumour sites rather than around wards.
That focus is the argument for choosing it. Cancer treatment is a sequence of decisions taken over months, and the quality of the first decision matters most. A centre that reviews every case in a multidisciplinary tumour board, re-reads its own pathology and has all three treatment modalities under one roof is more likely to get that first decision right.
Patients arriving from Bengaluru usually come for one of three reasons: a second opinion on a diagnosis, radiation therapy that is not available closer to home, or a full course of treatment at Indian prices.
Why patients choose HCG Cancer Hospital
Radiation therapy capability comes first. The network invested early and heavily in radiation technology, and the Bangalore flagship carries the most advanced equipment in the group, including options for stereotactic and image-guided treatment where those are clinically appropriate.
Second, the network structure. HCG operates centres across many Indian cities, so a patient can often have surgery or a complex plan set at the flagship and then receive routine chemotherapy cycles at a centre nearer home. Ask about this explicitly, because it can cut both cost and time away from family substantially.
Third, haematology and bone marrow transplant, with the isolation facilities and infection control that transplant requires.
Treatments offered at HCG Cancer Hospital
- Oncology & Cancer Medicine - medical oncology, chemotherapy, immunotherapy, targeted therapy, radiation therapy including stereotactic and image-guided techniques, surgical oncology and nuclear medicine
- Hematology & Blood Disorders - leukaemia, lymphoma, myeloma, myelodysplasia and marrow failure
- Stem Cell Therapy - autologous and allogeneic bone marrow transplant
- ENT Surgery - head and neck cancer surgery including oral, laryngeal and thyroid tumours
- Gynecology - gynaecological oncology for cervical, ovarian and uterine cancer
- Urology & Kidney Transplant - urological cancer of the kidney, bladder and prostate
- Gastroenterology - endoscopy and management of gastrointestinal cancer and its complications
- Hepatology & Liver Transplant - liver and biliary tract cancer
- General Surgery - surgical oncology for breast, thoracic and soft tissue tumours
- Neurosurgery - brain and spinal cord tumours
- Orthopaedics Joints & Spine Surgery - bone and soft tissue sarcoma, limb salvage surgery and spinal metastases
- Plastic & Cosmetic Surgery - microvascular reconstruction after tumour removal
- Pediatric Surgery - childhood solid tumours
- Dental Treatment - dental clearance before radiation and chemotherapy, prosthetic rehabilitation after head and neck surgery
- Endocrinology & Diabetes - thyroid cancer follow-up and management of diabetes during treatment
- Infectious Disease - infection in neutropenic and transplant patients
Questions that change a cancer plan
Bring the paraffin blocks or slides rather than only the typed report, because pathology is re-read here and a revised diagnosis or grade changes everything downstream. Ask whether molecular or genomic testing is indicated for your tumour and what it costs, since it increasingly determines drug choice. Ask for the case to go to a tumour board and for the conclusion in writing. Ask for the treatment costed per cycle with the number of cycles planned, and for the number of radiation fractions.
And ask the question people forget: what is the intent of treatment? Whether the aim is cure, control or symptom relief should be stated plainly, because it changes what side effects are worth accepting.